Pharma and laboratory594422-2026

Lithuania – Reagents and contrast media – Reagentai ir pagalbinės priemonės CAR-T gamybai I. (12116)

VšĮ Vilniaus universiteto ligoninė Santaros klinikos (PV)

Buyer country

Lithuania

Publication date

Not specified

Biderra sector

Pharma and laboratory

Data source

TED open data

Decision signals

First-pass opportunity review

These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.

Timing signal
Deadline not indexed

Check the official notice

Indexed data completeness
86%

Based on seven decision fields

Official title coverage
7 languages

Preserved from source-supplied versions

Classification signal
33696000

Medical equipment, pharmaceuticals and personal care products

Official title versions

TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.

Spanish

Lituania – Reactivos y medios de contraste – Reagentai ir pagalbinės priemonės CAR-T gamybai I. (12116)

Dutch

Litouwen – Reagentia en contraststoffen – Reagentai ir pagalbinės priemonės CAR-T gamybai I. (12116)

Polish

Litwa – Odczynniki i środki kontrastowe – Reagentai ir pagalbinės priemonės CAR-T gamybai I. (12116)

French

Lituanie – Réactifs et produits de contraste – Reagentai ir pagalbinės priemonės CAR-T gamybai I. (12116)

German

Litauen – Reagentien und Kontrastmittel – Reagentai ir pagalbinės priemonės CAR-T gamybai I. (12116)

Italian

Lituania – Reagenti e mezzi di contrasto – Reagentai ir pagalbinės priemonės CAR-T gamybai I. (12116)

English

Lithuania – Reagents and contrast media – Reagentai ir pagalbinės priemonės CAR-T gamybai I. (12116)

What Biderra adds

For notice 594422-2026, Biderra has normalized the contracting authority country as Lithuania, grouped CPV 33696000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.